Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Sleep Disordered Breathing at Altitude
NCT03536507Phase 4Completed
- Sponsor
- University of Zurich
- Start
- May 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in sleep disordered breathing (SDB), hypoxia, sponsored by University of Zurich. Started May 2018; status: completed.
02
Drugs
acetazolamide
03
Conditions
sleep disordered breathing (SDB)hypoxia
Beyond the preview
Go deeper on NCT03536507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03536507.